Clinical trial
A Study of Intra-dermal Injection of Botulinum Toxin Type A for the Diabetic…
NCT00336349 · Taipei Medical University Hospital, Other · Completed
Key facts
| NCT number | NCT00336349 |
|---|---|
| Title | A Study of Intra-dermal Injection of Botulinum Toxin Type A for the Diabetic Neuropathic Foot Pain |
| Official title | A Study of Intra-dermal Injection of Botulinum Toxin Type A for the Diabetic Neuropathic Foot Pain |
| Lead sponsor | Taipei Medical University Hospital, Other |
| Collaborators | Allergan Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Neuropathic Pain |
| Intervention type | Drug |
| Interventions | Botulinum Toxin Type A |
| Enrollment | 30 |
| Start date | Jun 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jun 13, 2006 |
| Last update posted | Jul 26, 2011 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: